Active ingredientRilmenidineCat. No. P-R058-001CAS 54187-04-1Family · Pharmaceutical analytical standards
Rilmenidine
A centrally acting antihypertensive that works on imidazoline receptors, reducing the activity of the sympathetic nervous system. It was authorised in France in 1987 for high blood pressure. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In 2023 a research team led from the University of Liverpool found that it extends the lifespan of the worm Caenorhabditis elegans, mimicking the effects of calorie restriction.
Go to the active ingredient →Active ingredientRilmenidineCat. No. P-R058-001CAS 54187-04-1
Isotopically labelledRilmenidine-d4Cat. No. P-R058-002CAS 85047-14-9
ImpurityRilmenidine Impurity ACat. No. P-R058-003CAS 54187-44-9
Active ingredientRilmenidine Dihydrogen PhosphateCat. No. P-R058-004CAS 85409-38-7
ImpurityRilmenidine Impurity BCat. No. P-R058-006
ImpurityRilmenidine Impurity CCat. No. P-R058-007No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.